The effects of commonly used adulterants on the detection of spiked LSD by an enzyme immunoassay

Science and Justice - Journal of the Forensic Science Society

Volumn 38, Issue 2, 1998, Pages 109-117

  Cassells, N P ^a   Craston, D H ^a  

^a LGC   (United Kingdom)

Author keywords

Adulteration; Drug screening; Enzyme immunoassay; Forensic science; Lysergic acid diethylamide; Urine

Indexed keywords

DOMESTIC CHEMICAL; LYSERGIDE;

ARTICLE; DRUG CONTAMINATION; DRUG URINE LEVEL; ENZYME IMMUNOASSAY; FORENSIC SCIENCE; PH;

EID: 0031898894     PISSN: 13550306     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1355-0306(98)72087-8     Document Type: Article

References (22)

1. Mikkelsen SL and Ash KO. Adulterants causing false negatives in illicit drug testing. Clinical Chemistry 1988; 34. 2333-2336.
2. Cody JT and Schwarzhoff RH. Impact of adulterants on RIA analysis of urine for drugs of abuse Journal of Analytical Toxicology 1989; 13: 277-284
3. Cody JT. Specimen adulteration in drug urinalysis. Forensic Science Review 1990; 2: 63-75.
4. Liu RH. Important considerations in the interpretation of forensic urine drug test results. Forensic Science Review 1992, 4: 51-65.
5. Morgan JP. Affidavit: in Zeese KB (Ed): Drug Testing Legal Manual. New York. NY: Clark Boardman. 1987. pB7-1.
6. Brunk SD. False negative GC/MS assay for carboxy THC-COOH due to ibuprofen interference. Journal of Analytical Toxicology 1988; 12: 290.
7. Blanke RV. Accuracy in urinalysis in urine testing for drugs of abuse; in Hawks RL, Chiang CN (Eds): Urine testing for drugs of abuse. Department of Health and Human Services, National Institute on Drug Abuse, Rockville, DC 1986: 43.
8. McBay AJ. Drug-analysis technology: pitfalls and problems of drug testing. Clinical Chemistry 1987; 33: 33B.
9. Warner M. Jumping to conclusions. Analytical Chemistry 1987; 59: 521A.
10. Warner A. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clinical Chemistry 1989; 35: 648-651.
11. Hoffman A. Steal this urine test. New York. NY: Penguin Books, 1987.
12. Latimer D. Reliability of drug tests. High Times 1986; Oct: 56.
13. Edwards C, Fyfe M, Liu R and Walia A. Evaluation of common urine specimen adulteration indicators. Journal of Analytical Toxicology 1993; 17: 252.
14. Schwarzhoff R and Cody JT. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. Journal of Analytical Toxicology 1993; 17: 14-17.
15. Cassells NP, Craston DH, Hand CW and Baldwin D. Development and validation of a non-isotopic immunoassay for the detection of LSD in human urine. Journal of Analytical Toxicology 1996; 20: 409-415.
16. Webb KS, Baker PB, Cassells NP, Francis JM, Johnston DE, Lancaster SL, Minty PS, Reed GD and White SA. The analysis of lysergide (LSD) the development of novel immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure. Journal of Forensic Sciences 1996; 41: 938-946.
17. Goldberger BA and Caplan YH. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay. Clinical Chemistry 1994, 40: 1605-1606
18. Spiehler V. UrinAid detection. Meeting report on the joint SOFT/CAT meeting, Phoenix, AZ, Oct 1993.
19. Bradley M and Schumann GB Examination of urine. In Henry JB (Ed): Clinical diagnosis and management by laboratory methods. Philadelphia, PA: WB Saunders Co., 1984; 393-395.
20. Operating manual for DA-100 Density/Specific Gravity Meter. Kyoto Electronics Manufacturing Co Ltd . Tokyo, Japan.
21. Nelson CC and Foltz RL. Determination of lysergic acid diethylamide (LSD), ISO-LSD, and N-demethyl-LSD in body fluids by gas chromatography/tandem mass spectrometry. Analytical Chemistry 1992; 64 1578-85.
22. Bukowski N and Eaton AN. The confirmation and quantitation of LSD in urine using gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 1993; 7: 106-8.